C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2006
11/16/2006	US20060258657 Apoptosis promoters
11/16/2006	US20060258653 Derivatives of sulphonamides, their preparation and use as medicaments
11/16/2006	US20060258612 CFTR channel modulators
11/16/2006	US20060257329 Delivery of drug esters through an inhalation route
11/16/2006	DE19948436B4 Bicyclische Imidazo-5-aminderivate Bicyclic imidazo-5-amine derivatives
11/16/2006	CA2608301A1 Pyrido[2,3-d]pyrimidines useful as hcv inhibitors, and methods for the preparation thereof
11/16/2006	CA2607874A1 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	CA2606595A1 Process for making fluorinated 4-azasteroid derivatives and intermediate thereof
11/16/2006	CA2602853A1 Ring closing and related methods and intermediates
11/15/2006	EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006	EP1721898A1 Quinoline and pyridoquinoxaline derivatives as antibacterial agents
11/15/2006	EP1721609A2 Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases
11/15/2006	EP1720878A1 Heteroaryl-fused pyrazolo derivatives
11/15/2006	EP1720874A1 4-substituted piperidine derivatives
11/15/2006	EP1720873A1 Diaza-spiropiperidine derivatives
11/15/2006	EP1720872A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
11/15/2006	EP1720871A1 3,5-disubstituted 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors
11/15/2006	EP1720870A1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
11/15/2006	EP1720868A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/15/2006	EP1720856A2 Hiv integrase inhibitors
11/15/2006	EP1720847A1 Histamine-3 receptor modulators
11/15/2006	EP1720829A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720545A1 Bicyclic and bridged nitrogen heterocycles
11/15/2006	EP1720542A1 Arylalkylamino-substituted quinazoline analogues
11/15/2006	EP1670778B1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
11/15/2006	EP1562945B1 1,4-diazabicyclo(3,2,2)nonane derivatives, preparation and therapeutical use thereof
11/15/2006	EP1453511B1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
11/15/2006	EP1414443B1 BENZIMIDAZO 4,5-f\|ISOQUINOLINONE DERIVATIVES
11/15/2006	EP1326610B1 Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1323711B1 Novel phenylalanine derivatives
11/15/2006	EP1244679B1 Purine derivatives
11/15/2006	CN1863891A Organic compound and organic light emitting device using the same
11/15/2006	CN1863802A Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
11/15/2006	CN1863801A Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of HIV and inflammation
11/15/2006	CN1863774A Compounds and compositions as protein kinase inhibitors
11/15/2006	CN1863771A Sequence selective pyrrole and imidazole polyamide metallocomplexes
11/15/2006	CN1863527A 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
11/15/2006	CN1862852A Application of organic sulfide in positive electrode material of secondary Mg battery
11/15/2006	CN1861600A Preparation process of taytrolazole
11/15/2006	CN1861599A Quinone carboxylic acid kind derivant, it preparation process and medicine application
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284781C Polycyclic compounds having anti-tumor activity
11/14/2006	US7135575 P38 inhibitors and methods of use thereof
11/14/2006	US7135568 Substituted pyrazolopyrimidines and thiazolopyrimidines
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135484 Azabicyclic compounds are central nervous system active agents
11/14/2006	US7135482 Aids therapy; viricides
11/14/2006	US7135480 Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosis
11/14/2006	US7135478 Analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
11/14/2006	US7135474 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction
11/14/2006	US7135469 Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
11/14/2006	US7135468 Antibacterial compounds
11/14/2006	CA2296427C 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives
11/14/2006	CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/14/2006	CA2128493C Aminobenzoic acid derivatives
11/09/2006	WO2006119504A2 Fused heterocyclic compounds, and compositions and uses thereof
11/09/2006	WO2006118978A2 Process for preparing nanoscale quinacridone
11/09/2006	WO2006118598A1 Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
11/09/2006	WO2006118534A1 Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux
11/09/2006	WO2006118212A1 Agent for preventing and treating pancreatitis
11/09/2006	WO2006117549A1 Enzyme inhibitors
11/09/2006	WO2006117383A1 Terrylene and quaterrylene derivatives
11/09/2006	WO2006117316A1 Mutual prodrug compounds for use us antiinflammatory agents with gastrointestinal protective activity
11/09/2006	WO2006117315A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protecctive activity
11/09/2006	WO2006117304A1 Tetracyclic azapyrazinoindolines as 5-ht2 ligands
11/09/2006	WO2006117221A1 Use of azapaullones for preventing and treating pancreatic autoimmune disorders
11/09/2006	WO2006100305A3 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging
11/09/2006	WO2006074293A3 Bicyclic dihydropyrimidines as eg5 inhibitors
11/09/2006	WO2006031491A3 Tricyclic anilide spirolactam cgrp receptor antagonists
11/09/2006	WO2006019673A3 Jiadifenin analogs and uses thereof
11/09/2006	US20060252937 Iodination of 4-aza-10,13-dimethyl-17-methoxycarbonyl gonan-3-one at the 2-position; displacement of iodine with fluorine; methylation of the lactam nitrogen; oxidation at the 1,2-position; hydrolysis of the ester; coupling with 2-aminomethyl imidazo[4,5-b]pyridine; androgen receptor modulator
11/09/2006	US20060252795 Chemokine receptor binding heterocyclic compounds
11/09/2006	US20060252793 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
11/09/2006	US20060252792 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
11/09/2006	US20060252791 Imidazo[4,5-c]pyridine compound and method of antiviral treatment
11/09/2006	US20060252790 e.g. 5-{5-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-1,3,4-oxadiazol-2-yl}-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine; antiinflammatory agent, antiallergen; cognitive impairment; asthma, arthritis
11/09/2006	US20060252789 Amorphous moxifloxacin hydrochloride
11/09/2006	US20060252784 Imidazo-substituted 1,8-naphthyridinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
11/09/2006	US20060252783 Imidazo-substituted pyrido[2,3-d]pyrimidinylamines; treating arthritis, Crohn's disease, Alzheimer's disease, irritable bowel syndrome, adult respiratory distress syndrome, and chronic obstructive pulmonary disease.
11/09/2006	US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006	US20060252777 5-[4-(6,7-Dimethoxy-quinolin-4-yloxy)-3-fluoro-phenyl]-2-(4-fluoro-phenylamino)-3-methyl-3H-pyrimidin-4-one; anticarcinogenics, antimetastasis agents, antiproliferatives, angiogenesis inhibitors; hepatocyte growth factor mediated diseases
11/09/2006	US20060252765 Corneal perception recovery drug containing amide compound
11/09/2006	US20060252754 Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same
11/09/2006	US20060252679 Preventive and/or trerapeutic drgs for itch
11/09/2006	US20060252093 Heterocyclic organic molecules through intramolecular formation of n-acyliminium ions
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	US20060249052 Process for preparing nanoscale quinacridone
11/09/2006	CA2607524A1 Agent for prophylaxis and treating of pancreatitis
11/09/2006	CA2606760A1 Tetrahydronaphthyridine and tetrahydropyrido[4,3-d]pyrimidine compounds and compositions thereof useful in the treatment of conditions associated with neurological and inflammatory disorders and disfunctions
11/09/2006	CA2605900A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity
11/09/2006	CA2605895A1 Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity
11/09/2006	CA2599411A1 Enzyme inhibitors
11/08/2006	EP1719775A1 Camptothecins with a modified lactone ring
11/08/2006	EP1719773A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
11/08/2006	EP1719771A1 Pyrazoloquinolone derivative and use thereof
11/08/2006	EP1719770A2 Quinoline derivatives as antibacterials
11/08/2006	EP1719768A1 Novel benzothiazepine and benzothiepine compounds

1 ... 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 ... 646